Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-57,911
Closed -$4.38M 504
2026
Q1
$4.38M Sell
57,911
-238
-0.4% -$17.9K 0.05% 273
2025
Q4
$4.33M Sell
58,149
-1,783
-3% -$130K 0.05% 272
2025
Q3
$4.04M Sell
59,932
-388
-0.6% -$25.8K 0.05% 288
2025
Q2
$3.93M Sell
60,320
-656
-1% -$39.3K 0.05% 282
2025
Q1
$3.77M Buy
+60,976
New +$4.04M 0.06% 268

Other funds holding HOLX

ASR Vermogensbeheer's HOLX Position: Q2 2026 in Review

ASR Vermogensbeheer sold out of Hologic (HOLX) in Q2 2026, closing a stake of 57,911 shares — an estimated $4.38M sold.

ASR Vermogensbeheer first reported a position in HOLX in Q1 2025 and held it in 5 quarters. The position peaked at $4.38M in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • ASR Vermogensbeheer reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • ASR Vermogensbeheer sold 57,911 Hologic shares in Q2 2026, an estimated $4.38M.
  • ASR Vermogensbeheer first reported a position in Hologic in Q1 2025 and held it in 5 quarters.
  • ASR Vermogensbeheer's Hologic position peaked at $4.38M in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.